These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10961543)

  • 1. Syntheses of four peptides from the immunodominant region of hepatitis C viral pathogens using PS-TTEGDA support for the investigation of HCV infection in human blood.
    Kumar KS; Rajasekharan Pillai VN; Das MR
    J Pept Res; 2000 Aug; 56(2):88-96. PubMed ID: 10961543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of immunodominant peptide regions of hepatitis C viral pathogens using PS-BDODMA resin: a single peptide derived from the conserved domain (E2/NS1) was highly effective in detecting anti-HCV antibodies.
    Kumar KS; Roice M; Sasikumar PG; Poduri CD; Sugunan VS; Rajasekharan Pillai VN; Das MR
    J Pept Res; 2001 Feb; 57(2):140-50. PubMed ID: 11168897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient gel-phase synthesis of peptides on a high capacity flexible crosslinked polystyrene support: comparison with Merrifield resin.
    Krishna Kumar M; Rajasekharan Pillai VN; Mathew B
    J Pept Sci; 2002 May; 8(5):183-91. PubMed ID: 12043993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
    Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
    Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synthesis and antigenic activity of peptides from the C-terminal part of the NS4-protein of the hepatitis A virus].
    Semiletov IuA; Firsova TV; Kuzin SN; Khudiakov IuE; Shibnev VA
    Bioorg Khim; 1993 Nov; 19(11):1128-31. PubMed ID: 8285926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
    Sällberg M; Rudén U; Wahren B; Magnius LO
    Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of human immune response to potential hepatitis C viral epitopes.
    Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
    Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tri(propylene glycol) glycerolate diacrylate cross-linked polystyrene: a new resin support for solid-phase peptide synthesis.
    Sasikumar PG; Kumar KS; Rajasekharan Pillai VN
    J Pept Res; 2003 Jul; 62(1):1-10. PubMed ID: 12787445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and antigenic activity of peptides from core- and NS3-proteins of hepatitis C virus].
    Semiletov IuA; Firsova TV; Shibnev VA; Viazov SO
    Bioorg Khim; 1993 Jan; 19(1):126-9. PubMed ID: 8387305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus].
    Semiletov IuA; Firsova TV; Kruglov IV; Alekseenkova TI; Petrakova NV; Kalinina TI; Shibnev VA
    Vopr Virusol; 1998; 43(3):107-9. PubMed ID: 9702806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of antibodies to the nucleocapsid protein of Hepatitis C virus by immunoenzyme analysis using synthetic peptides of nucleocapsid N-terminal part].
    Firsova TV; Alekseenkova TI; Shibnev VA; Froesner G; Semiletov IuA
    Vopr Virusol; 2001; 46(2):21-4. PubMed ID: 11392965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
    Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
    J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses, characterization and application of cross-linked polystyrene-ethyleneglycol acrylate resin (CLPSER) as a novel polymer support for polypeptide syntheses.
    Leena S; Kumar KS
    J Pept Res; 2001 Aug; 58(2):117-28. PubMed ID: 11532071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
    Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
    Khudyakov Yu E; Khudyakova NS; Jue DL; Lambert SB; Fang S; Fields HA
    Virology; 1995 Jan; 206(1):666-72. PubMed ID: 7530398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b.
    Carlos MP; Yamamura Y; Vu Q; Conzen K; Anderson DE; Torres JV
    Clin Immunol; 2004 Apr; 111(1):22-7. PubMed ID: 15093548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft shell resins for solid-phase peptide synthesis.
    Lee TK; Choi JH; Ryoo SJ; Lee YS
    J Pept Sci; 2007 Oct; 13(10):655-61. PubMed ID: 17712866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
    Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
    J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection.
    Zibert A; Kraas W; Ross RS; Meisel H; Lechner S; Jung G; Roggendorf M
    J Hepatol; 1999 Feb; 30(2):177-84. PubMed ID: 10068093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.